The GPR37 gene gives instructions for a receptor, a cell surface signal receiver, used mainly in the brain to support nerve cell communication and the cells that help form myelin, the protective covering around nerves. If it does not work well, brain signaling and myelin support may be affected, which can influence movement and other nervous system functions. In medicine, this gene is important because it has been studied in Parkinson disease and other brain conditions, although most gene changes in GPR37 are not known to cause disease.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do much of the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they are turned on. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
GPR37Gene function
What if the gene works
The GPR37 gene helps brain cells send signals and stay healthy. It is especially active in cells involved in movement and may support how these cells handle stress.
Risk
What if the gene does not work
Changes in the GPR37 gene can range from milder to more severe variants. These changes may alter how this cell signaling protein folds, reaches the cell surface, or responds to signals, disrupting communication between certain brain cells.
Treatment
What does that mean for your treatment
No GPR37-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the GPR37 gene. The GPR37 gene is being studied as a possible drug target and biomarker in Parkinson disease and some cancers, but this has not changed routine treatment choices.
Gene function
What if the gene works
In the brain, the GPR37 gene helps cells receive and fine tune signals from their surroundings. Its activity is especially important in nerve cells and in cells that make myelin, the fatty covering that insulates nerves. Understanding what the GPR37 gene does helps show how brain cells coordinate routine communication and support.
The GPR37 gene helps certain brain cells detect outside chemical cues at the cell surface. These cues are then turned into internal signals that guide everyday cell activity.
In oligodendrocytes (brain cells that make myelin), the GPR37 gene supports normal maturation. This helps these cells take part in building and maintaining myelin, the fatty layer that insulates nerves.
By shaping signaling inside cells, the GPR37 gene helps nearby nerve cells and support cells work in a coordinated way. This supports smooth communication across brain tissue.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GPR37 gene can change the receptor’s shape, making it less stable, harder to move to the cell surface, or less able to pass signals inside the cell. Milder variants may only partly reduce receptor folding and signaling, while more disruptive variants can sharply lower the amount of working receptor or stop it from being made. This range helps explain how GPR37 gene variants affect receptor folding and signaling.
How variants are linked to conditions
Right now, the GPR37 gene does not yet have a broadly confirmed link to a specific health condition, though this can change as research develops. In other words, current evidence on how GPR37 gene variants are linked to conditions is still evolving, so any confirmed GPR37-related diagnosis is best interpreted with guidance from a doctor or genetic counselor.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect natural variation among people. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the GPR37 gene. Research is ongoing, but this gene is not used on its own to predict a clear personal risk pattern. Anyone with concerns about inherited risk should speak with a doctor or genetic counselor.
Inheritance of GPR37 variants
There is not yet a broadly confirmed, disease-specific Mendelian pattern for how GPR37 gene variants are inherited, so the answer about GPR37 gene variants inherited in families is still evolving. GPR37 is located on chromosome 7, which is an autosome. That means you inherit one copy of the GPR37 gene from your mother and one copy from your father. Any health effects linked to a GPR37 variant would depend on the specific variant and the condition being studied.
What does my GPR37 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific medical condition for GPR37, though this can change as research grows. If you have a specific GPR37 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your family history and health.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for GPR37 variants usually uses a blood or saliva sample. A lab reads the DNA in the GPR37 gene and compares it with a reference sequence to identify variants, then classifies any findings based on their likely health relevance.
When should I consider getting a genetic test?
There isn't yet a broadly established GPR37-specific reason for genetic testing in routine care. Testing decisions are usually based on your symptoms and family history and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can be informative, but what they can tell you varies with the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body handles some medicines, so the same treatment may work differently from one person to another. These common differences can affect how a drug is broken down, moved through the body, or recognized by its target, which may change how well it works or how sensitive someone is to side effects. Medication response also depends on age, overall health, and other medicines, so genes are one part of the picture.
What is Pharmacogenetics?
Pharmacogenetics studies how differences in genes can affect the way a person responds to medications. By examining connections between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are both better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the GPR37 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. If you have concerns about side effects, how well a treatment is working, or possible medicine interactions, it is best to discuss them with your doctor or pharmacist.
History
The GPR37 gene entered the research literature in the late 1990s, during a period of growing interest in genes active in the brain. Early attention increased when scientists linked GPR37 to studies of Parkinson disease and to work on the PARK2 pathway, which made the gene more visible in neurology research. From these first observations, research expanded steadily, and investigators explored how changes in GPR37 might connect with brain cell stress and movement-related conditions. Over time, scientists’ understanding of the gene’s role has changed, especially as newer laboratory methods gave a clearer picture than the earliest reports. While GPR37 has not become a major public-facing gene, it remains part of the scientific history of Parkinson-related genetics.